226 related articles for article (PubMed ID: 22950544)
1. Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis.
Marson FA; Bertuzzo CS; Ribeiro AF; Ribeiro JD
BMC Pulm Med; 2012 Sep; 12():50. PubMed ID: 22950544
[TBL] [Abstract][Full Text] [Related]
2. Variants in the interleukin 8 gene and the response to inhaled bronchodilators in cystic fibrosis.
Furlan LL; Ribeiro JD; Bertuzzo CS; Salomão Junior JB; Souza DRS; Marson FAL
J Pediatr (Rio J); 2017; 93(6):639-648. PubMed ID: 28719800
[TBL] [Abstract][Full Text] [Related]
3. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.
Rabe KF; Fabbri LM; Israel E; Kögler H; Riemann K; Schmidt H; Glaab T; Vogelmeier CF
Lancet Respir Med; 2014 Jan; 2(1):44-53. PubMed ID: 24461901
[TBL] [Abstract][Full Text] [Related]
4. Role of
Scaparrotta A; Franzago M; Marcovecchio ML; Di Pillo S; Chiarelli F; Mohn A; Stuppia L
J Aerosol Med Pulm Drug Deliv; 2019 Jun; 32(3):164-173. PubMed ID: 30855197
[No Abstract] [Full Text] [Related]
5. Beta 2 adrenergic receptor polymorphisms in cystic fibrosis.
Hart MA; Konstan MW; Darrah RJ; Schluchter MD; Storfer-Isser A; Xue L; Londono D; Goddard KA; Drumm ML
Pediatr Pulmonol; 2005 Jun; 39(6):544-50. PubMed ID: 15806595
[TBL] [Abstract][Full Text] [Related]
6. Influence of SNPs in Genes that Modulate Lung Disease Severity in a Group of Mexican Patients with Cystic Fibrosis.
Yokoyama E; Chávez-Saldaña M; Orozco L; Cuevas F; Lezana JL; Vigueras-Villaseñor RM; Rojas-Castañeda JC; Landero DA
Arch Med Res; 2018 Jan; 49(1):18-26. PubMed ID: 29703608
[TBL] [Abstract][Full Text] [Related]
7. Influence of pancreatic status, CFTR mutations, Staphylococcus aureus and/or Pseudomonas aeruginosa infection/colonization on lung function in cystic fibrosis during a 2-year follow-up period.
Pascoal MA; Marson FAL; Paschoal IA; Levy CE
Wien Klin Wochenschr; 2020 Oct; 132(19-20):572-580. PubMed ID: 32356101
[TBL] [Abstract][Full Text] [Related]
8. Effect of ADRB2 (adrenergic receptor β2) gene polymorphisms on the occurrence of asthma and on the response to nebulized salbutamol in South Indian patients with bronchial asthma.
Shah NJ; Vinod Kumar S; Gurusamy U; Annan Sudarsan AK; Shewade DG
J Asthma; 2015 Oct; 52(8):755-62. PubMed ID: 25985706
[TBL] [Abstract][Full Text] [Related]
9. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
[TBL] [Abstract][Full Text] [Related]
10. beta2 adrenoceptor gene polymorphisms in cystic fibrosis lung disease.
Büscher R; Eilmes KJ; Grasemann H; Torres B; Knauer N; Sroka K; Insel PA; Ratjen F
Pharmacogenetics; 2002 Jul; 12(5):347-53. PubMed ID: 12142724
[TBL] [Abstract][Full Text] [Related]
11. Association of clinical severity of cystic fibrosis with variants in the SLC gene family (SLC6A14, SLC26A9, SLC11A1 and SLC9A3).
Pereira SV; Ribeiro JD; Bertuzzo CS; Marson FAL
Gene; 2017 Sep; 629():117-126. PubMed ID: 28756021
[TBL] [Abstract][Full Text] [Related]
12. β(2) -adrenoreceptor polymorphisms in asthmatic and non-asthmatic schoolchildren from Colombia and their relationship to treatment response.
Isaza C; Sepúlveda-Arias JC; Agudelo BI; Arciniegas W; Henao J; Porras GL; Beltrán L
Pediatr Pulmonol; 2012 Sep; 47(9):848-55. PubMed ID: 22328447
[TBL] [Abstract][Full Text] [Related]
13. Combined pharmacogenetic effect of ADCY9 and ADRB2 gene polymorphisms on the bronchodilator response to inhaled combination therapy.
Kim SH; Ye YM; Lee HY; Sin HJ; Park HS
J Clin Pharm Ther; 2011 Jun; 36(3):399-405. PubMed ID: 21545619
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of the influence of ADRB2 genetic polymorphisms on albuterol (salbutamol) therapy in patients with asthma.
Hikino K; Kobayashi S; Ota E; Mushiroda T; Urayama KY; Kobayashi T
Br J Clin Pharmacol; 2021 Apr; 87(4):1708-1716. PubMed ID: 32986886
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study.
Marson FA; Bertuzzo CS; Ribeiro AF; Ribeiro JD
BMC Med Genet; 2014 Mar; 15():27. PubMed ID: 24593045
[TBL] [Abstract][Full Text] [Related]
16. Genetic interaction of GSH metabolic pathway genes in cystic fibrosis.
de Lima Marson FA; Bertuzzo CS; Secolin R; Ribeiro AF; Ribeiro JD
BMC Med Genet; 2013 Jun; 14():60. PubMed ID: 23758905
[TBL] [Abstract][Full Text] [Related]
17. An investigation of the association between ADRB2 gene polymorphisms and asthma in Kazakh population.
Akparova A; Aripova A; Abishev M; Kazhiyakhmetova B; Pirmanova A; Bersimbaev R
Clin Respir J; 2020 Jun; 14(6):514-520. PubMed ID: 32034992
[TBL] [Abstract][Full Text] [Related]
18. Asthma: Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic receptor gene as risk factors.
de Paiva AC; Marson FA; Ribeiro JD; Bertuzzo CS
Allergy Asthma Clin Immunol; 2014 Feb; 10(1):8. PubMed ID: 24499171
[TBL] [Abstract][Full Text] [Related]
19. Acute and chronic lung function responses to salmeterol and salmeterol plus fluticasone propionate in relation to Arg16Gly beta(2)-adrenergic polymorphisms.
Yancey SW; Klotsman M; Ortega HG; Edwards LD; Anderson WH
Curr Med Res Opin; 2009 Apr; 25(4):1011-8. PubMed ID: 19275519
[TBL] [Abstract][Full Text] [Related]
20. Relationship between polymorphisms in the 5' leader cistron, positions 16 and 27 of the adrenergic β2 receptor gene and asthma in a Han population from southwest China.
Fu WP; Zhao ZH; Zhong L; Sun C; Fang LZ; Liu L; Zhang JQ; Wang L; Shu JK; Wang XM; Dai LM
Respirology; 2011 Nov; 16(8):1221-7. PubMed ID: 21801278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
